IV ketamine staves off suicide in the short term: study
New placebo-controlled trial shows two infusions a day apart leads to full remission in more patients at day three
More patients with severe suicidal ideation achieve full remission in the short term with intravenous ketamine than those not treated with the drug, reports a new placebo-controlled trial
However, the French researchers caution that the potential for abuse and lack of longer-term benefit may limit the drug’s use for this indication.
